CamNtech is the successor to Cambridge Neurotechnology. CNT was founded by Nigel Oakley and Gary Ungless and the company was the inventor of the Actiwatch product range.
Following the acquisition of the Actiwatch range by Philips/Respironics in April 2008 CamNtech purchased from Cambridge Neurotechnology the worldwide rights to manufacture and distribute the Actiheart.
CamNtech continues Cambridge Neurotechnology's tradition for innovative engineering and since the Actiwatch acquisition the company has launched several new product ranges. This includes the Actiwave, Cardio and PRO-Diary product ranges.
|September 2009||CamNtech launches the PRO-Diary, a new compact wrist worn diary for collecting subjective patient information.|
|November 2008||First Actiwave paper is published in ‘Medicine du Sommeil.’ Please see the bibliography for full details.|
|August 2008||CamNtech takes over from Cambridge Neurotechnology. Dr Nigel Oakley, co-founder of CNT, retires.|
|June 2008||CamNtech launches the new Actiwave range of waveform recorders at an event in Cambridge.|
|April 2008||Philips Respironics acquires the Actiwatch product range from Cambridge Neurotechnology.|
|September 2007||CNT launches the new Actiwatch AW7; the world’s most advanced Actiwatch.|
|2003||CNT launches the Actiheart combined heart rate and activity monitor.|
|2002||CNT wins the Queens Award for Enterprise Innovation.|
|1996||CNT launches the Actiwatch AW4.|
|1995||Cambridge Neurotechnology founded by Gary Ungless and Nigel Oakley.|